Marsam
Executive Summary
Generic injectables firm completes validation batches and receives FDA approval to ship material from a new plant located at the company's Cherry Hill, N.J. site. The new $7 mil., 28,000 sq. ft. plant is dedicated to the manufacture of non-penicillin, non- cephalosporin injectables